靶点针对疾病信息18(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
TARGNAME
Enhancer of zeste homolog 2 (EZH2)
INDICATI
Approved Brain cancer [ICD-11: 2A00]
INDICATI
Approved Diffuse large B-cell lymphoma [ICD-11: 2A81]
INDICATI
Approved Peritoneal cancer [ICD-11: 2C51]
INDICATI
Approved Synovial sarcoma [ICD-11: 2B5A]
INDICATI
Phase 2 Lung cancer [ICD-11: 2C25]
INDICATI
Phase 2 Mature B-cell lymphoma [ICD-11: 2A85]
INDICATI
Phase 2 Mature T-cell lymphoma [ICD-11: 2A90]
INDICATI
Phase 2 Ureteral cancer [ICD-11: 2C92]
INDICATI
Phase 1/2 B-cell lymphoma [ICD-11: 2A86]
INDICATI
Phase 1/2 Malignant haematopoietic neoplasm [ICD-11: 2B33]
INDICATI
Phase 1/2 Prostate cancer [ICD-11: 2C82]
INDICATI
Investigative Breast cancer [ICD-11: 2C60-2C6Y]